Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiyuki Tsunoda

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Anticancer Research|June 20, 2013
Roles of ZFAT in haematopoiesis, angiogenesis and cancer developmentToshiyuki Tsunoda, Senji Shirasawa
Anticancer Research|August 1, 2025
PrefaceToshiyuki Tsunoda, Toyofumi Hirakawa
Anti-Cancer Drugs|April 4, 2026
3-Aminoisoquinolines inhibit selectively phosphodiesterase 4B in KRAS-mutated colorectal cancer cell lines in-vitro and in-vivoGennady B Lapa, Toshiyuki Tsunoda, Natalia I Moiseeva
The Journal of Biological Chemistry|September 26, 2022
Death domain-associated protein DAXX regulates noncoding RNA transcription at the centromere through the transcription regulator ZFATShuhei Ishikura, Kazumasa Yoshida, Toshiyuki Tsunoda, et al.
Anticancer Research|July 27, 2023
MMP-2 Regulation of Emmprin on Tumour Cells and CD73 on Fibroblasts During Tumour-Stromal InteractionMikiko Aoki, Toshiyuki Tsunoda, Kaori Koga, et al.
Nucleic Acids Research|September 30, 2020
ZFAT binds to centromeres to control noncoding RNA transcription through the KAT2B-H4K8ac-BRD4 axisShuhei Ishikura, Kazuhiko Nakabayashi, Masayoshi Nagai, et al.
The Journal of Dermatology|September 18, 2018
Acquisition of resistance to vemurafenib leads to interleukin-10 production through an aberrant activation of Akt in a melanoma cell lineTakashi Inozume, Toshiyuki Tsunoda, Takashi Morisaki, et al.
Anticancer Research|June 30, 2016
Resveratrol Overcomes Cellular Resistance to Vemurafenib Through Dephosphorylation of AKT in BRAF-mutated Melanoma CellsHao Luo, Masayo Umebayashi, Keiko Doi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 27, 2007
Association analysis of glutathione-S-transferase P1 (GSTP1) polymorphism with urothelial cancer susceptibility and myelosuppression after M-VAC chemotherapyAkira Yokomizo, Ken Yamamoto, Naoko Kinukawa, et al.
Anticancer Research|July 31, 2014
Resveratrol induces luminal apoptosis of human colorectal cancer HCT116 cells in three-dimensional cultureToshiyuki Tsunoda, Shuhei Ishikura, Keiko Doi, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Anticancer Research|June 20, 2013
Roles of ZFAT in haematopoiesis, angiogenesis and cancer developmentToshiyuki Tsunoda, Senji Shirasawa
Anticancer Research|August 1, 2025
PrefaceToshiyuki Tsunoda, Toyofumi Hirakawa
Anti-Cancer Drugs|April 4, 2026
3-Aminoisoquinolines inhibit selectively phosphodiesterase 4B in KRAS-mutated colorectal cancer cell lines in-vitro and in-vivoGennady B Lapa, Toshiyuki Tsunoda, Natalia I Moiseeva
The Journal of Biological Chemistry|September 26, 2022
Death domain-associated protein DAXX regulates noncoding RNA transcription at the centromere through the transcription regulator ZFATShuhei Ishikura, Kazumasa Yoshida, Toshiyuki Tsunoda, et al.
Anticancer Research|July 27, 2023
MMP-2 Regulation of Emmprin on Tumour Cells and CD73 on Fibroblasts During Tumour-Stromal InteractionMikiko Aoki, Toshiyuki Tsunoda, Kaori Koga, et al.
Nucleic Acids Research|September 30, 2020
ZFAT binds to centromeres to control noncoding RNA transcription through the KAT2B-H4K8ac-BRD4 axisShuhei Ishikura, Kazuhiko Nakabayashi, Masayoshi Nagai, et al.
The Journal of Dermatology|September 18, 2018
Acquisition of resistance to vemurafenib leads to interleukin-10 production through an aberrant activation of Akt in a melanoma cell lineTakashi Inozume, Toshiyuki Tsunoda, Takashi Morisaki, et al.
Anticancer Research|June 30, 2016
Resveratrol Overcomes Cellular Resistance to Vemurafenib Through Dephosphorylation of AKT in BRAF-mutated Melanoma CellsHao Luo, Masayo Umebayashi, Keiko Doi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 27, 2007
Association analysis of glutathione-S-transferase P1 (GSTP1) polymorphism with urothelial cancer susceptibility and myelosuppression after M-VAC chemotherapyAkira Yokomizo, Ken Yamamoto, Naoko Kinukawa, et al.
Anticancer Research|July 31, 2014
Resveratrol induces luminal apoptosis of human colorectal cancer HCT116 cells in three-dimensional cultureToshiyuki Tsunoda, Shuhei Ishikura, Keiko Doi, et al.
Pageof 8